FDA Investigator Sha'tina R Alridge

Sha'tina R Alridge has conducted inspections on 53 sites in 1 countries as of 19 Jul 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
53
Last Inspection Date:
19 Jul 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
100005543
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Sha'tina R Alridge:
Ademola O Daramola, Albert F Peacock, PhD, Andrea A Branche, Andrew B Bevill, Anh M Lac, Aqualia L Nelson, Ariel Cruz Figueroa, Blondell W Johnson, Brackens Harris, Brandi E Williams, Brandon C Heitmeier, Brandon K Barbee, Brenda G Stewart Munoz, Brook Shea, Camerson E Moore, Carlos Chavez, Carol A Declouette Wilburn, Cathleen A Castellaw, Charles B Steinmiller, Charles D Brown, Cheryl L Watson, Christopher D Rush, Christopher J Hurst, Christopher N Tran, Claire M Minden, Constance M Dobbins, Crystal S Harris, Daniel J Lahar, Daniel S Fam, Danielle Lyke, Danielle M Maddox, Darla J Christopher, David M Beltran, Dawn P Hall, Debra D Devlieger, Demario L Walls, Denise Connelly, Djamila Harouaka, Dr. Jason R Caballero, Ed Gonzalez Vazquez, Edward D Edmiston, Edwin Ramos, Elizabeth Ad Girard, Elizabeth D Connell, Ellen J Tave, Emilio O Escobar, Ernest Serna, III, Florecia S Philogene, Francis A Guidry, Franklin R Harris, Frans E Mercado, Frederic W French, III, George J Flynn, Gery M Duparc, Gilbert Valdez, RS, Gretchen M Laws, H Ljamilla Selby, Habacuc V Barrera, Hala L Selby, Hung V Le, Iris C Macinnes, Jacob S Foster, Jai P Singh, Jamie M Bumpas, Janice M Hickok, Jeffrey R Wooley, Jennifer A Downie, Jocelyn C Turner, Jodi M Gatica, Johann M Fitch, John Ahearn, Johnson, Jonaida Estevez Martinez, Jose Martinez, Jr, Joy L Ramsey, Kamara Tx, Karen C Daugherty, Kari M Johansen, Kari M Laynor, Karlton T Watson, Katherine E Jacobitz, Kathleen Chmura Shaffer, Kayla V Sprague, Kelly D Sheppard, Kenitra D Hewitt, Kevin T Nguyen, Krista W Whitten, L Grant, Latorie S Jones, Lauren E Skokan, Lisa M Pence, Lisa M Puttonen, Lisa M Yoder, Lisa R Jennings, Lisa R Whitt, Lloyd D Payne, Lorie S Hannappel, Lourdes R Genera, Lucas B Leake, Maira P Brading, Margaret M Annes, Markeesa M Scales, Massoud Motamed, Matthew R Maddox, Matthew S Mccollough, Michelle A Krayer, Mikel T Wright, Monique Rac Lester, Nicole E Knowlton, Nimmy Mathews, Patrice S Hall, Patricia M Jacobs, Patrick D Stone, MS, Patty P Kaewussdangkul, Paul E Frazier, Pauline N Logan, Philip M Steele, PhD, Priya J Rathnam, Qing Delgado, Regan T Harp, Rene R Ramirez, Robert T Lorenz, Rose Ashley, Samuel A Hamblin, Sandy J Ziegler, Sandy L Atkins, Scott T Ballard, Sean C Johnson, Shanna N Purdy, Sharon K Thoma, PharmD, Shawn E Larson, Shelby N Turner, Sherrie L Krolczyk, Sina Shojaee, Sonia R Peterson, Stephen D Brown, Stephen L Beekman, Steven L Strom, Suzanne N Vallez, Tamera H Hunt, Thomas J Arista, Timothy H Vo, Torrance J Slayton, Tricia S Martinez, Tricia Y Samaniego, Trina K Vick, Unnee Ranjan, Uttaniti Limchumroon (Tom), Yasamin Ameri, Yumi J Hiramine, Zachary L Miller, Zerita White

Sha'tina R Alridge's Documents

Publish Date Document Type Title
March, 2020 FDA 483 Unilever Manufacturing (US), Inc. - Form 483, 2020-03-10
August, 2016 FDA 483 Massco Dental - Form 483, 2016-08-18
April, 2017 FDA 483 Brio Pharmaceuticals, Inc. - Form 483, 2017-05-12
March, 2017 FDA 483 ICU Medical INC. - Form 483, 2017-03-10
May, 2015 FDA 483 Response Blue Bell Creameries, L.P. - Form 483R, 2015-05-22
October, 2015 EIR BASF Corporation - EIR, 2015-10-23
April, 2017 EIR Brio Pharmaceuticals, Inc. - EIR, 2017-04-26
February, 2019 FDA 483 Kelada Creative Group, LLC - Form 483, 2019-02-01
August, 2017 FDA 483 Option Care - Form 483, 2017-08-02
January, 2020 FDA 483 Bio-Medical Pharmaceutical Manufacturing Corporation - Form 483, 2020-01-23
May, 2022 FDA 483 Marlinz Pharma, LLC - Form 483, 2022-05-04
June, 2017 FDA 483 QuVa Pharma, Inc. - Form 483, 2017-06-02
January, 2018 FDA 483 Empower Clinic Services LLC dba Empower Pharmacy - Form 483, 2018-01-24
July, 2022 EIR Aphena Pharma Solutions - Tennessee, LLC - EIR, 2022-07-22
May, 2015 FDA 483 Blue Bell Creameries, L.P. - Form 483, 2015-05-01

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more